Insulin‐like growth factor‐1 infusion in preterm piglets does not affect growth parameters of skeletal muscle or tendon tissue

• Published in: Experimental physiology Vol. 109; no. 9; pp. 1529 - 1544
• Main Authors: Tangbjerg, Malene, Damgaard, Ann, Karlsen, Anders, Svensson, Rene B., Schjerling, Peter, Gelabert‐Rebato, Miriam, Pankratova, Stanislava, Sangild, Per Torp, Kjaer, Michael, Mackey, Abigail L.
• Format: Journal Article
• Language: English
• Published: England John Wiley & Sons, Inc 01.09.2024; Wiley
• Subjects: Animals; Animals, Newborn; Birth weight; Collagen (type I); Elastin; Female; Gene expression; growth; Growth factors; IGF‐1; Immunofluorescence; Immunoreactivity; Insulin; Insulin-Like Growth Factor I - metabolism; Insulin-like growth factors; Insulin-Like Peptides; Maturation; Metabolic disorders; Muscle Fibers, Skeletal - drug effects; Muscle Fibers, Skeletal - metabolism; Muscle, Skeletal - drug effects; Muscle, Skeletal - growth & development; Muscle, Skeletal - metabolism; Musculoskeletal system; postnatal; Premature Birth; Satellite cells; Skeletal muscle; Swine; Tendons - drug effects; Tendons - metabolism; Vascularization; IGF‐1; postnatal; growth
• ISSN: 0958-0670; 1469-445X; 1469-445X
• DOI: 10.1113/EP092010

Prematurity has physical consequences, such as lower birth weight, decreased muscle mass and increased risk of adult‐onset metabolic disease. Insulin‐like growth factor 1 (IGF‐1) has therapeutic potential to improve the growth and quality of muscle and tendon in premature births, and thus attenuate some of these sequalae. We investigated the effect of IGF‐1 on extensor carpi radialis muscle and biceps brachii tendon of preterm piglets. The preterm group consisted of 19‐day‐old preterm (10 days early) piglets, treated with either IGF‐1 or vehicle. Term controls consisted of groups of 9‐day‐old piglets (D9) and 19‐day‐old piglets (D19). Muscle samples were analysed by immunofluorescence to determine the cross‐sectional area (CSA) of muscle fibres, fibre type composition, satellite cell content and central nuclei‐containing fibres in the muscle. Tendon samples were analysed for CSA, collagen content and maturation, and vascularization. Gene expression of the tendon was measured by RT‐qPCR. Across all endpoints, we found no significant effect of IGF‐1 treatment on preterm piglets. Preterm piglets had smaller muscle fibre CSA compared to D9 and D19 control group. Satellite cell content was similar across all groups. For tendon, we found an effect of age on tendon CSA, and mRNA levels of COL1A1, tenomodulin and scleraxis. Immunoreactivity for elastin and CD31, and several markers of tendon maturation, were increased in D9 compared to the preterm piglets. Collagen content was similar across groups. IGF‐1 treatment of preterm‐born piglets does not influence the growth and maturation of skeletal muscle and tendon. What is the central question of this study? Does infusion of insulin‐like growth factor‐1 in preterm piglets stimulate growth parameters of muscle and tendon? What is the main finding and its importance? IGF‐1 treatment of preterm born piglets does not influence growth and maturation of skeletal muscle and tendon. This adds to the current knowledge on the effect of IGF‐1 on muscle and tendon growth, and is relevant for future research in potential therapies for premature infants.